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INTRODUCTION
Labor is an extremely painful process. Traditionally a number of techniques have been 
employed to provide labor analgesia. Epidural analgesia is considered to be the gold standard in labor 
analgesia. Continuous epidural analgesia is ideal to provide analgesia because of the long duration of 
labor. Traditionally only high doses of local anesthetics were used. Though they provide excellent pain 
relief, they produce an unacceptably high level of motor blockade which impairs the parturient’s ability 
to bear down during labor, resulting in prolonged labor. Lower doses of Bupivacaine (0.04% -0.125%) 
by themselves are inadequate.
The discovery of opioid receptors in spinal analgesia provides an interesting option. Opioid 
agonists selectively block pain impulses but leave the motor system intact. Doses used for central 
neuraxial blockade are also very little compared to other parenteral routes and does not result in 
significant fetal depression. Since opioids and local anesthetics acts at different sites their combination 
provides a synergistic effect permitting us to use lesser concentrations of both. When used in such low 
doses their individual side effects are minimized while maximizing the desired effects.
Current obstetric practice aims to provide effective pain relief while     Efforts to improve 
epidural analgesia led to Collins and colleagues1 popularizing the combined spinal-epidural technique 
(CSE) for analgesia in labor. This technique involved an initial Intrathecal injection of opioids 
(Fentanyl) and Bupivacaine to establish analgesia, and subsequent epidural injections to maintain the 
analgesia. The doses of drugs involved were such that ambulation in labor was possible. However after 
the initial Intrathecal injection, motor blockade was present for up to 20 min. Recent research has 
shown that, in the absence of motor weakness there is no functional impairment of balance in laboring 
women and therefore ambulation is safe30.
Ropivacaine is a newer local anaesthetic, which has been shown to cause less motor weakness 
and less cardio toxicity and is rapidly evolving as local anaesthetic of choice in Labor analgesia as well 
as in post operative analgesia37, 38, 39, 40. The aim of this study was to compare Intrathecal injection of 
Fentanyl 0.025 mg and Bupivacaine 2.5 mg, with an Intrathecal injection of Fentanyl 0.025 mg and 
Ropivacaine 2.5 mg as a part of CSE in labor analgesia. Efficacy, sensory and motor blockade and fetal 
effects were studied in detail.
The CSE technique was selected so that the analgesia will be maintained by Epidural route in 
both the groups even though the study stops short with the comparison of Intrathecal injection of 
Bupivacaine and Fentanyl with Ropivacaine and Fentanyl.
                                                           AIM
To compare Intrathecal Bupivacaine and Ropivacaine with Fentanyl in labor analgesia with 
regard to: 
1. Efficacy of pain relief
2. Effect on fetal and maternal outcomes
3. Patient comfort and the ease of ambulation during labor.
4. Safety
                  
                          
HISTORY
Throughout history women suffered with pain until the advent of using ether for labor analgesia 
by Dr.James Young Simpson of Edinburgh on 19th January 1847, which opened up the interesting 
avenue of pain relief for labor. At that time it was a highly controversial issue. 
Labor analgesia became popular when John Snow administered chloroform anesthesia to Queen 
Victoria for the birth of her 8th child Prince Leopold in 1853 and 9th child Princess Beatrice in 1857. 
Kinkovich of St.Petersburg used Nitrous Oxide in Obstetric analgesia in 1880.Guedel designed an 
apparatus for the self-administration of nitrous oxide in labor in 1910.
Dennis Jackson and Striker used Trichloroethylene in 1934. Freedman inhaler was developed in 
1943 to facilitate administration of analgesic concentrations of Trichloroethylene to women in labor.
Methoxyflurane was used for labor in 1959 and in 1970. Even midwives were permitted to use 
0.35% Methoxyflurane.
Tunstall tried Entonox in 1962.Inhalation anesthesia for labor is not much used now except 
Entonox. Following the demonstration of spinal analgesia by August Bier in 1899 this was also tried 
for labor but without much success.
Stoeckel of Marburg described extradural sacral block in 1909 using Procaine. This was 
followed by Schlimpert and Schneider who used 50ml of 1% Procaine.
Eugen Bagden in 1930 and J.G.P.Clealand of University of Oregon in 1933 provided important 
contributions to the understanding of the anatomical pathways and physiology of labor pain. 
Fidel Pages of Spain performed the first lumber epidural block in 1921 and Dogliotti of Turin 
developed the technique in 1930. Refinements in the needle by Tuohy and in the catheter quality made 
continuous epidural analgesia a popular technique. The flexibility introduced by the continuous 
epidural technique with regard to the duration was especially very suitable for labor because of the 
longer duration required for successful labor analgesia. The CSE technique combines the advantages of 
both spinal and epidural analgesia.
The discovery of opioid receptors in the central nervous system by Snyder in 1973 and Pert in 
1976 was soon followed by flurry of activity. A number of opioids have been used successfully both 
Intrathecally and extradurally. Highly lipophilic opioids like Fentanyl, Sufentanil and Alfentanil are 
more suitable than less lipophilic drugs like morphine. Opioids provide excellent pain relief when used 
Intrathecally or extradurally without affecting the motor system – a property that is much desired in an 
agent used for labor analgesia. 
ANATOMY OF THE EPIDURAL AND SUBARACHNOID   SPACE
THE EPIDURAL SPACE
The epidural (extradural, peridural) space is that part of the vertebral canal external to the 
duramater and its contents. It lies between the dura and the periosteum lining the canal, and 
corresponds to the very restricted space within the skull between the two layers of the cranial dura 
mater enclosing the venous sinuses.
BOUNDARIES
Anteriorly: By vertebral bodies and posterior longitudinal ligaments
Posteriorly: Vertebral arches and ligamentum flavum
Superiorly: Fusion of dura with periosteum at foramen magnum
Inferiorly: Sacrococcygeal ligament at sacral hiatus
The epidural space extends from the Foramen magnum to sacral hiatus. Except in the lower 
sacral region it is annular in shape, and narrow. The anterior and posterior nerve roots with their dural 
coverings pass across the very narrow space to unite in the intervertebral foramen to form the 
segmental nerves. The rest of the epidural space is occupied by numerous small veins and by fatty 
areolar tissue, which is continuous around the nerves through the intervertebral foramina with the fat in 
the paravertebral spaces. The upward spread of drugs is limited by the attachment of dura to the 
circumference of the foramen magnum.
The amount of fat in the areolar tissue of the space depends on the obesity of the subject. It is 
greatest in the median plane posteriorly where the summit of the vertebral arch is commonly separated 
from the rounded posterior aspect of the dura by approximately 5 to 6 mm, and antero-laterally where it 
is continuous with the pads of fat surrounding the spinal nerves in the intervertebral foramina. Between 
the postero-lateral walls of the lumbar vertebral canal and the dura, the space is narrower, and the fat 
less evident. Anteriorly in a thin subject, the space is only potential, since here the dura lies close to the 
posterior longitudinal ligament on the posterior aspect of the vertebral bodies.
The spread of the local analgesic solution injected into the epidural space is not accurately 
predictable, because of the resistance offered by the fatty areolar tissue and the numerous foramina 
through which the fluid can leak. A dorso-median fold of dura mater was demonstrated in a few cases, 
which sometimes divides the epidural space into a ventral and two dorso-lateral compartments, not 
necessarily freely communicating with each other. The median thickness of the space might be only 2 
mm. These observations explain the occasional patchy analgesia and inadvertent dural puncture when 
the midline approach is used.
The space occupied by the venous plexus varies with the amount of the venous distention and is 
related to the intrathoracic pressure.
SUBARACHNOID SPACE
The subarachnoid space is lined externally by the arachnoid, internally by the piamater, and 
innumerable cobweb like trabeculae run between the two membranes, though sparsely in the cisterns, 
the cranial and spinal nerves traverse it. It houses the main blood vessels of the central nervous system, 
and extends along the smaller arteries and capillaries in to the substance o the brain and the spinal cord. 
Here the cerebrospinal fluid takes the place of the tissue fluid (lymph) found in other regions of the 
body.
          In the cervical and thoracic regions the space is annular and the distance between the arachnoid 
and pia covering the cord, even in an adult is only about 3mm, so that a spinal tap here is fraught with 
the danger of injuring the cord with the needle. The cord commonly ends at the lower end of the first 
lumbar vertebra so that below this level the subarachnoid space is no longer annular but it is practically 
circular in section and has a diameter of about 15mm. Lumbar puncture should be carried out in the 
lower lumbar region. The fact that the cord terminates above this level renders it immune to injury, the 
constituent nerve roots of the cauda equina escape damage on account of their limited mobility, and the 
absence of the cord greatly increases the cross sectional area of the sub arachnoid space, the ultimate 
target at which the needle is aiming.  
PRESSURE AND VOLUMES OF THE EPIDURAL SPACE
Substantial differences have been observed between the actions of epidural and subarachnoid 
injections of local anesthetics in the pregnant and non-pregnant patient. In many respects the changes 
are thought to be due to the mechanical effects of the pregnancy as the actual size of the space available 
is reduced. The return of blood from the lower part of the body is mainly via the inferior vena cava; the 
epidural veins are also involved and they become dilated. This reduces the space available for the 
injection of fluid into the epidural space. For the same reason, the subarachnoid space is also reduced. 
As these veins are an alternate method of returning lower limb blood flow, their use is maximized if 
there is an obstruction to vena cava return as can happen in pregnancy.
There are three effects from this:
 The volume of local anaesthetic required to provide an extensive block is reduced in pregnancy.
 There is an increased risk of puncture of the distended veins by either the spinal or epidural 
needles or the catheter.
 Distension is likely to be maximum in the sitting position and pressure in the epidural space is 
also increased.
For the above reasons pressure in the epidural space is increased, particularly in the sitting 
position. During a contraction, as the blood expelled from the contracting uterus passes to the epidural 
venous plexus, the pressure in the epidural space may rise by 4-10 cms H2O. It is for this reason that 
injections of local anesthetics should be withheld during a contraction, as the spread may be 
unpredictable and probably excessive.
Although the engorgement of the epidural veins would appear to be increased in the sitting 
position, there is little evidence to suggest that the lateral position is associated with a decrease in 
complication rates such as dural puncture or reduced incidence of venous puncture.
                        PHYSIOLOGY OF PAIN IN LABOR
Pain as described by the International association for study of pain (ISAP) is “an unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or as described in 
terms of such damage”.
PATHWAYS AND MECHANISM
Bonica has modified the description of peripheral pain pathways proposed by Cleland in 1993.
PAIN IN THE FIRST STAGE OF LABOR
Uterine contractions cause stretching, tearing and distortion and possibly ischemia of the uterine 
tissues, whilst simultaneously dilating the cervix and stretching the lower uterine segment. The 
intensity of the pain increases progressively with the raising strength of the contractions. In early labor 
only the nerve roots of T11 and T12 are involved, but as the intensity of contractions increases, T10 
and L1 are recruited.
Backache is a frequent complaint during labor and may be caused by two mechanisms. Pain 
originating in the uterus or cervix may be referred to the cutaneous branches of the posterior divisions 
of T10-L1. Pressure on peri uterine tissues often, in association with fetal malposition or an unusual 
shape of the sacrum, refer to the L5-S1 segments.
PAIN IN THE SECOND STAGE OF LABOR
The pain caused by the distension of the pelvic structure and perineum following descent of the 
presenting part is added to the pain of uterine contractions, although once cervical dilatation is 
complete the pain induced by uterine contractions may become less severe. The uterine pain continues 
to be referred to T10-L1, while the pain produced by stretching or pressure exerted on intrapelvic 
structures, including the peritoneum, bladder, urethra and rectum is referred to sacral segments. 
Pressure on the roots of the lumbosacral plexus may manifest itself, as pain felt low in the back or in 
the thighs. Pain produced by stretching of the perineum is transmitted by the pudendal nerve (S2, 3, 4) 
and in part by the posterior cutaneous nerve of the thigh (S2, 3), the genitofemoral nerve (L1, 2) and 
the ilio-inguinal nerve (L1).
CLINICAL IMPLICATIONS
During the first stage of labor, a block limited to the T11-T12 segments at the beginning and 
later extending to involve T10 and L1 will usually be sufficient to provide excellent pain relief whilst 
avoiding neural blockade of the sacral segments. Premature sacral blockade can result in the loss of the 
stimulating effect upon contractions of Ferguson’s reflex and the loss of pelvic muscle tone, which aids 
the rotation of the presenting part.
Later in the first stage and during the early part of the second stage, pain is often experienced in 
lower lumbar and upper sacral segments, so that the block will have to be extended if analgesia is to be 
guaranteed.
Complete block of the sacral segments need to be performed only when perineal pain becomes 
worrisome.
Epidural block will interrupt the preganglionic sympathetic fibers and leave the postganglionic 
fibers intact.
RELAY OF PAIN
Pain from the peripheral nociceptive field is transmitted to the cortex by the afferents arising 
from the dorsal root ganglion i.e., the first order neurons. The majorities of these first order neurons 
passes to the contralateral side as the spinothalamic tract and gives afferents to the medullar centre, 
reticular activating system, and hypothalamus and reach the post central gyrus in the cortex. The 
efferent impulses reach the segmental area through the corticospinal and rubrospinal tracts.
Some of the first order neurons communicate through the intern uncial neurons and give 
efferent impulses to the peripheral nociceptive areas from the segmental autonomic reflexes.
Labor and vaginal delivery produces tissue damage, and like tissue injury from any cause, result 
in pain and local segmental, suprasegmental and cortical responses.
Pain relief during labor provides excellent satisfaction for the mother in labor. Lumbar epidural 
analgesia is far superior to parenteral and inhalational approaches, as the mother remains alert 
throughout and the analgesia can be extended to relieve both uterine pain and pain related to distension 
of the lower birth canal, thus providing analgesia for instrumental delivery or caesarean sections. 
Regional analgesia minimizes or completely avoids the problems of maternal aspiration, as well as 
neonatal drug depression due to general anesthesia.
CONSEQUENCES OF PAIN IN LABOR
Pain is a noxious and unpleasant stimulus, which produces fear and anxiety. It was once thought 
that fear, anxiety and ignorance exacerbated labor pain. But the opposite may also be true.
The maternal and fetal consequences of unrelieved pain in labor has been stressed on many an 
occasion. Unrelieved pain in labor causes increased plasma cortisol and catecholamine levels. This may 
be responsible for the decrease in the utero-placental blood flow. Effective pain relief reduces plasma 
noradrenalin levels, prevents the rise of 11-hydroxycorticosteroid in the first and second stages. It also 
prevents metabolic acidosis by reducing the rate of rise of lactate, pyruvate and decreases maternal 
oxygen consumption by up to 14%. Effective epidural analgesia prevents the pain induced 
hyperventilation and hypocapnia, which can be severe enough to produce tetany in painful labor. The 
respiratory alkalosis further impairs feto-maternal gas exchange by shifting the oxygen dissociation 
curve to the left and the fall of fetal PaO2.
                       PHYSIOLOGICAL CONSIDERATIONS
RESPIRATORY SYSTEM
During labor, particularly in the late first stage and second stage, the pain from episodic uterine 
contractions produce corresponding increases in maternal minute ventilation (as much as 300% over 
that of non pregnant women) and oxygen consumption. Maternal hypocarbia (PaCO2 <=20mmHg) and 
alkalemia (pH 7.55) results. Hypocarbia can lead to hypoventilation between uterine contractions, 
resulting in intermittent hypoxemia (particularly in obese patients or those who have received 
parenteral opioids). Epidural analgesia eliminates these pain-induced increases in oxygen consumption 
and minute ventilation and the accompanying hyperventilation-hypoventilation cycle. Pain, which 
causes the pregnant woman to hyperventilate, shifts the oxygen dissociation curve to the left. This 
increases the maternal oxygen affinity and makes the unloading of oxygen to the fetus less favorable.
During pregnancy, capillary engorgement of the mucosa occurs throughout the respiratory tract, 
potentially causing edema in the nasopharynx, oropharynx, larynx and trachea. Therefore, manipulation 
of the upper airway requires extreme care. Regional analgesia abolishes the requirement of airway 
manipulation and hence avoids the dangers involved in general anesthesia.
CARDIOVASCULAR CHANGES
The cardiovascular system is progressively stressed during pregnancy and parturition. Many of 
the changes appear during the first trimester of pregnancy increases in cardiac output of 22% and 
decrease in systemic vascular resistance by 30% at 8 weeks gestation). The changes continue into the 
second and early third trimester of pregnancy, when cardiac output increases to approximately 30-40% 
of non-pregnant values. The increase in cardiac output during pregnancy is primarily a result of 
increase in stroke volume (by about 30%) with a more modest increase in heart rate (10-15 beats/min). 
Arterial blood pressure does not change during normal pregnancy because of a decrease in peripheral 
vascular resistance.
Clinical examination of a pregnant woman may reveal a wide, loud split first sound and a soft 
ejection systolic murmur, caused by the increased blood flow and vasodilatation. The elevated 
diaphragm usually alters the position of the heart at term, so that the point of maximum impulse is felt a 
little to the left. The axis on the ECG is also shifted to left. ECG may show non-specific ST, T and Q 
wave changes and benign arrhythmias.
The pain and apprehension of labor adds to cardiac work during pregnancy and increases stroke 
volume and cardiac output by 45% over prelabor values. Blood pressure increases during painful labor. 
Additional stresses are imposed by uterine contractions, which cause, in effect an auto transfusion. 
With each uterine contraction, blood from the body of the uterus is pushed into the central circulation 
and blood volume and cardiac output increase by 10-25%. After delivery also the same auto transfusion 
occurs. In addition to increase in central blood volume, obstruction of the venacava is relieved. As a 
result there is a marked increase (up to 80% of pre labor values) in stroke volume and cardiac output in 
the immediate post partum. Patients with limited cardiac reserve may experience cardiac failure at this 
time.
Despite the increase in blood volume and cardiac output, the parturient at term is susceptible to 
hypotension in supine position. When the patient is supine, the gravid uterus partially or completely 
compresses the aorta and inferior vena cava, leading to decreased venous return, decreased cardiac 
output, hypotension and reduced uterine blood flow. Up to 10% of pregnant patients near term develop 
signs of shock (hypotension, pallor, sweating, nausea, vomiting, changes in cerebration) when they 
assume this position. 
Compensatory mechanisms include increased sympathetic tone and collateral routes 
(paravertebral veins to azygos vein) to improve venous return during obstruction of the vena cava. 
Caval compression also increases uterine venous back pressure, which further decreases uterine blood 
flow. Compression of the aorta is not associated with maternal symptoms but does cause arterial 
hypotension in the lower extremities and uterine arteries, which can further decrease uterine blood flow 
and impair utero-placental perfusion.
 During labor the patient should be positioned either on her side or with a left tilt. During 
delivery the operating or the delivery table can be tilted laterally to the left or a small pillow or foam 
rubber wedge can be used to elevate the patient’s right buttock and back to about 10-15 cms.
The pregnant woman at term is in a hypercoagulable state owing to increase in factors VII, VIII, 
X and plasma fibrinogen. Estimation of blood loss at delivery varies but may be around 500ml for an 
uncomplicated vaginal delivery. Blood loss during caesarean section varies widely with 500 to 1400 
ml, being reported.
HEPATIC CHANGES
Total protein concentration and the albumin- globulin concentration ratio decrease. Although 
plasma cholinesterase activity is reduced during pregnancy and in the immediate post partum period, 
moderate doses of Succinylcholine are usually metabolized easily.
GASTRO INTESTINAL CHANGES
During pregnancy, the secretion of gastric acid increases. During late pregnancy, gastric 
emptying is slowed as a result of displacement of pylorus by the enlarged uterus. Pain, anxiety and use 
of opioid analgesia during labor contribute to impaired gastric emptying. Intra-gastric pressure is 
increased and lower esophageal sphincter tone is decreased during pregnancy. All these changes 
increase the risk of regurgitation and aspiration during either during general anaesthesia or during the 
state of impaired consciousness from any other cause.
CENTRAL NERVOUS SYSTEM CHANGES
Pregnancy reduces anesthetic requirements both during regional and general anesthesia. During 
spinal or epidural anesthesia, less local anesthetic is required to produce a given level of anesthesia. 
This was thought to be due to the mechanical effects of increased intra-abdominal pressure, causing 
epidural venous engorgement and a reduction of both the epidural and subarachnoid spaces. Reduced 
MAC is seen during early pregnancy and immediate post partum period.
RENAL CHANGES
Renal blood flow and glomerular filtration rate increase rapidly during pregnancy, reflecting 
changes in cardiac output. During the third trimester, they slowly return to normal. Creatinine clearance 
usually increases and therefore the upper limits of normal for blood urea nitrogen and serum creatinine 
are lower in the pregnant woman.
UTERINE BLOOD FLOW
Uterine blood flow in the parturient at term is approximately 700ml/min and is determined by 
the following relationship:
Uterine blood flow = (uterine arterial pressure) - (uterine venous pressure)
          (Uterine vascular resistance)
There is auto regulation of uterine blood flow. The vessels are maximally dilated during 
pregnancy. As such in the absence of aortic compression, uterine arterial pressure directly reflects 
maternal blood pressure and cardiac output. Uterine blood flow decreases during maternal hypotension 
(sympathetic block, hypovolemia, hemorrhage, compression of the inferior vena cava), in 
circumstances in which uterine venous pressure is increased (compression of the inferior venacava, 
abruption placenta), and with increases in uterine vascular resistance (maternal hypertensive disorders, 
α agonists, uterine hypercontracitility). Due to increased maternal mean arterial pressure and a 
concomitant decrease in uterine blood flow there are deleterious effects on the fetus. 
After epidural analgesia uterine blood flow increases, mean arterial pressure stabilizes and 
placental blood flow is increased by either a reduction in extrinsic vascular tone (uterine tone) or a 
decrease in intrinsic vascular resistance (placental vasodilatation). 
EFFECTS OF LABOR PAIN ON THE FOETUS
During uterine contractions there is intermittent reduction of the intervillous blood flow and during 
a peak of contraction, there may be a temporary decrease in the placental gas exchange. This is 
worsened by maternal hyperventilation due to severe pain.
 Respiratory alkalosis in the mother results in the following:
• A shift of the mother’s oxygen dissociation curve to the left, diminishing transfer of oxygen 
form mother to the fetus. 
• Maternal hypoxia during uterine relaxation.
• Umbilical vasoconstriction causing a diminution of umbilical blood flow.
• A reduction in uterine blood flow due to elevations in noradrenalin levels.
• Fetal hypoxia
Normally maternal blood receives acid metabolites and carbon dioxide from fetal blood and the 
pH decreases so that there is shift in the maternal oxyhaemoglobin dissociation to the right maintaining 
increased oxygen delivery to the fetus. At the same time in fetal blood, the pH increases leading to a 
shift in fetal oxygen dissociation curve to the left. This effect is known as the double Bohr Effect. In 
prolonged labor maternal hyperventilation leads to alkalosis and with diminishing maternal PaCO2, the 
Bohr Effect may be attenuated and cause hypoxia in conditions of fetal stress. Thus maternal 
hyperventilation as a result of pain decreases fetal oxygenation, presumably by shifting the maternal 
oxygen dissociation curve to the left and by reducing umbilical blood flow.
EFFECTS OF MATERNAL ANALGESIA
Maternal hyperventilation is reduced as a result of adequate pain relief. The periods of 
hyperventilation during contractions followed by hypoventilation during relaxation are avoided and 
PaCO2 remains in the near normal range. Hypoxia consequent to hypoventilation in between 
contraction is also avoided. Epidural analgesia, by blocking impulses as well as sympathetic efferents 
reduces the release of catecholamines, cortisol and ACTH, reducing the stress response.
Analgesia also reduces the marked rise in cardiac output and blood pressure due to pain. These may be 
especially beneficial to the parturient with cardiac disease, PIH and pulmonary hypertension. Maternal 
and fetal acidosis is also reduced.
EFFECTS ON THE FOETUS
The benefits of pain relief, best achieved by regional techniques, are likely to be of value to all infants 
but are especially important to the fetus at risk. Epidural analgesia increases intervillous blood flow by 
vasodilatation and may attenuate the pre-existent vasoconstriction in PIH.
PHARMACOLOGY OF BUPIVACAINE
HISTORY
It is an amide linked local anesthetic synthesized by B.A.F Ekenstam in 1957 and introduced 
into clinical practice by Talivuo in 1963.
STRUCTURE
An amino amide local anesthetic having aromatic moiety (benzene ring), which offers 
liphophilicity at one end of the molecule. It is linked by an amide to a tertiary amine, which is 
hydrophilic on the other end of the molecule.
MOLECULAR FORMULA
It displays stereoisomerism: marketed as a racemic mixture containing optically active 
enantiomers, R and S. S-enantiomer has been noted to have a slightly longer duration of action and 
lower systemic toxicity when compared to its R-type.
MECHANISM OF ACTION
The base form is in equilibrium with cationic form outside the axoplasmic membrane. Base 
form diffuses inside the cell and recalibrates with cationic form. It then reaches the local anesthetic 
receptor in the Na+ channel by reversing channel pore while it is in an open state. It prevents Na+ ions 
moving intracellularly.
In addition to this simple sodium channel blockade, it also affects second messenger system 
such as adenylate cyclase and guanylate cyclase and also inhibits synaptic transmission by modification 
of post synaptic receptor (or) presynaptic calcium channel blockade in epidural / subarachanoid 
blockade.
PHYSIOCHEMICAL PROPERTIES
Property Value
Molecular weight 288
Potency ratio 15
Toxicity ratio 10
pKa(25.C) 8.16
Protein binding in %
Maternal 95
Fetal 66
% non ionized at
pH 7.4 17
pH 7.2 11
Partition co-efficient
(25.C, pH 7.4) 346
Anesthetic index 3.0-4.0
PHARMACOKINETICS OF EPIDURAL BUPIVACAINE
The uptake of local anesthetic into blood vessels in the area where it has been deposited and its 
subsequent transfer into systemic circulation is referred to as systemic absorption.
ABSORPTION
A biphasic absorption pattern has been found for epidural Bupivacaine. The rapid initial 
absorption following epidural administration is most likely related to high concentration gradient 
between the drug in the solution and in the blood. In addition profound increases in epidural blood flow 
observed during epidural administration of Bupivacaine may contribute to its fast initial absorption 
rate.
Later on, after the local anaesthetic has been taken up into local tissues such as epidural fat, 
absorption will become dependent on tissue blood partitioning, resulting in marked slowing of 
absorption. Estimated total fraction of the dose ultimately absorbed into general circulation is 0.94 with 
mean absorption time 8.6 hours.
Absorption of local anesthetic is directly related to the amount of drug injected, vascularity, site 
injected and tissue binding of local anesthetic at injection site. Bupivacaine will produce lower Cmax 
than less potent and less lipid soluble agents.
DISTRIBUTION
Distribution of local anesthetic has special emphasis in the pregnant patient, because one of the 
organs that will be exposed to the absorbed drug is fetoplacental unit.
PHARMACOKINETICS OF BUPIVACAINE
Elimination half-life t1/2β - 162 minutes
Volume of distribution VDSS - 73 lit
Clearance (lit/min) - 0.6
Hepatic extraction - 0.4
BIODEGRADATION AND ELIMINATION
Liver is the site of metabolism. Two major factors controlling the clearance of the amide-linked 
local anesthetic are hepatic blood flow and hepatic function. The principal pathways are N-
dealkylation, aromatic hydroxylation and amide hydrolysis.
CLINICAL CHARACTERISTICS OF BUPIVACAINE
Property Value
Penetrance Moderate
Duration 6-8 hrs
Infiltration 0.05%
Field block 0.1%
Pudendal / paracervical 0.125%
Epidural analgesia 0.125 – 0.25%
Extradural motor 0.5 – 0.75%
Maximal dose 2mg/kg body weight
ADVERSE EFFECT AND COMPLICATIONS
Central Nervous System Toxicity
Potentially toxic blood level can occur when a drug is injected intravenously, intra arterially or 
a large dose of drug is given into highly vascular area. Risk of CNS toxicity is more because 
Bupivacaine is a highly protein bound drug. Pregnancy is associated with 30% reduction in protein 
binding. This allows for higher brain level of Bupivacaine for a given dose of drug.
Symptoms
Slow speech, jerky movements, tremors, hallucination, and seizure.
Cardiovascular Toxicity41, 42
1. Dose dependant depression of contractility
2. Dose dependent depression of conduction and velocity in all conducting tissues. 
Progressive prolongation of ventricular conduction.
3. Predisposition to reentry phenomenon followed by sudden onset of ventricular 
fibrillation.
4. More affinity for cardiolipin
Toxic plasma concentration is 4-5 µg/ml.
PHARMACOLOGY OF ROPIVACAINE
GENERIC NAME : Ropivacaine HCl Injection
CHEMICAL NAME S-(-)-1-propyl-2’,6’-pipecoloxylidide hydrochloride monohydrate
PHYSICAL PROPERTIES
The  drug  substance  is  a  white  crystalline  powder,  with  a  chemical  formula  of 
C17H26N2O•HCl•H2O,  molecular  weight  of  328.89.  At  25°C  Ropivacaine  HCl  has  a 
solubility of 53.8 mg/mL (0.164 mol/L) in water, a distribution ratio between n-octanol and 
phosphate buffer at pH 7.4 of 141 and a pKa of 8.07 in 0.1 M KCl solution 43,44. The pKa of 
Ropivacaine  is  approximately  the  same  as  Bupivacaine  (8.1)  and  is  similar  to  that  of 
mepivacaine  (7.7).  However,  Ropivacaine  has  an  intermediate  degree  of  lipid  solubility 
compared to Bupivacaine and mepivacaine.  The solubility  of  Ropivacaine is  limited at  pH 
above 6. Thus, care must be taken as precipitation may occur if Ropivacaine is mixed with 
alkaline solutions.
CHEMICAL PROPERTIES
Ropivacaine HCl Injection is a member of the amino amide class of local anesthetics. It 
is chemically described as S-(-)-1- propyl-2’, 6’-pipecoloxylidide hydrochloride monohydrate 
36.  Ropivacaine  is  structurally  similar to Bupivacaine and mepivacaine.  However,  it  differs 
from these drugs in that they are racemic preparations, while Ropivacaine is available as the 
S-(-)  enantiomer.  The  drug  substance  has  a  chemical  formula  of  C17H26N2O•HCl•H2O, 
molecular weight of 328.89, and the following structural formula:
STRUCTURAL FORMULA OF ROPIVACINE
PHARMACOLOGICAL ClASSIFICATION
Ropivacaine HCl Injection is a member of the amino amide class of local anesthetics. It 
is a homologue of Bupivacaine and mepivacaine. Systemic absorption of local anesthetics can 
produce effects on the central nervous and cardiovascular systems. At blood concentrations 
achieved with therapeutic  doses,  changes  in  cardiac  conduction,  excitability,  refractoriness, 
contractility,  and  peripheral  vascular  resistance  are  minimal.  However,  toxic  blood 
concentrations depress cardiac conduction and excitability, which may lead to atrioventricular 
block,  ventricular  arrhythmias,  and  to  cardiac  arrest,  sometimes  resulting  in  fatalities.  In 
addition, myocardial contractility is depressed and peripheral vasodilation occurs, leading to 
decreased  cardiac  output  and  arterial  blood  pressure  37,  38,  39,  40,  41,  42  .  Following  systemic 
absorption, local anesthetics can produce central nervous system stimulation, depression, or 
both. Apparent central stimulation is usually manifested as restlessness, tremors, and shivering, 
progressing  to  convulsions,  followed  by  depression  and  coma,  progressing  ultimately  to 
respiratory arrest. 
Mechanism of action
 Ropivacaine is a member of the amino amide class of local anesthetics and is supplied 
as the pure S-(-)-enantiomer.  Local anesthetics  block the generation and the conduction of 
nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, 
slowing the  propagation  of  the  nerve  impulse,  and  reducing  the  rate  of  rise  of  the  action 
potential.
PHARMACOKINETICS
Elimination: The kidney is the main excretory organ for most local anesthetic metabolites. In 
total, 86% of the Ropivacaine dose is excreted in the urine after intravenous administration, of 
which only 1% relates to unchanged drug.
PHARMACOLOGY OF FENTANYL
STRUCTURE
4 anilinopiperidines that are structurally related to pethidine.
Fentanyl is a synthetic opioid with morphine like actions. Act at µ receptors as a agonist. It is 
more specific, shorter acting and 80-100 times more potent than morphine.
PHARMACODYNAMICS OF FENTANYL
CARDIOVASCULAR SYSTEM
Bradycardia – vagal stimulation in high doses.
No effect on cardiac contractility
Hypotension in large doses due to bradycardia, venodilation and suppression of central sympathetic 
out flow.
RESPIRATORY SYSTEM
Dose dependent respiratory depression through direct action on medullary respiratory centre. 
Effects are:
- Apnoeic threshold increased.
- Hypoxic drive decreased
- Delayed respiratory depression.
CENTRAL NERVOUS SYSTEM
Analgesia, euphoria, sedation, hyponosis, miosis, nausea, vomiting.
Gastrointestinal tract: Delays gastric emptying produces biliary colic.
Endocrine system:   Attenuation of stress response
PHARMACOKINETICS / PHYSIOCOCHEMICAL PROPERTIES
Property Value
pKa 8.4
% unionized at pH 7.4 <10
Percentage bound to plasma protein 84
t ½ µ 1 – 2 mins
t ½ α 10 – 30 mins
t ½ β 2 – 4 hour
Vdcc L/kg 0.5 – 1.0 L /Kg
Vdss L/kg 3 -5 L/kg
Clearance 10 – 20 ml/kg/mt
Hepatic extraction ratio 0.8 – 1.0
CLINICAL PROPERTIES
Minimal CSF spread, Rapid onset, Short duration, Low CSF solubility, Rapid analgesia, Decreased 
side effects, Ideal for PCEA.
DISADVANTAGES
Systemic absorption, Brief single dose analgesia.
When applied intraspinally these opioids should be injected as close as possible to the spinal 
segments where the previous nociceptive afferent, carrying the nociceptive impulses from the involved 
dermatomes enter the spinal cord. 
PHARMACOLOGY OF EPIDURAL FENTANYL
Dose = 50 -200 µg
Onset = 5 – 15 minutes
Duration = 2 – 4 hours after single dose
SIDE EFFECTS
Pruritis, sedation, nausea and vomiting, urinary retention, apnoea and seizures, chest wall 
rigidity.
REVIEW OF LITERARTURE
CES viz., Epidural Analgesia for Labor pain:
1. Collins RE, Davies DW, Aveling W, Lancet 1995 Jun 3;                 345(8962):  1413-6:1 
The authors carried out a randomized observational study to assess maternal satisfaction with the 
standard and combined techniques among 197 women in labor. Overall satisfaction was greater in the 
combined spinal-epidural group than in the standard epidural group. Good analgesia was achieved in 
both groups, but the combined spinal-epidural had faster onset of analgesia and more of this group 
were satisfied with analgesia at 20 min (92/98 vs 68/99, p < 0.0001). 12 women in the combined 
spinal-epidural group had leg weakness (as shown by an inability to raise the straight legs) at 20 min, 
but this initial motor block had resolved in most of these mothers by 1 h. In the standard epidural group 
32 had leg weakness at 20 min (p = 0.001), and the proportion of mothers with weakness increased in 
this group during labor. Overall, women seem to prefer the low-dose combined spinal-epidural 
technique to standard epidurals, perhaps because of the faster onset, less motor block, and feelings of 
greater self-control 
2. Landau R et al, Semin Perinatol 2002 Apr 26; 109-21:2
 The authors reviewed various studies comparing Epidural and CSE. They concluded, “CSE should be 
considered a major breakthrough in the management of labor analgesia”. The advantages of the CSE 
include more rapid onset of analgesia, reduced total drug dosage, minimal or no motor blockade and 
increased patient satisfaction. CSE has also been associated with more rapid cervical dilation when 
compared to epidural analgesia in nulliparous women in early labor.
Safety of Intrathecal Ropivacaine
3. Malinovsky et al, Anesthesiology. 97(2): 429-435, August 2002 5 
The authors experimentally determined the relationship between doses of Intrathecal Ropivacaine and 
spinal effects and local neurotoxic effects. Seven days after the last Intrathecal injection spinal cord and 
nerves were sampled for histopathologic study. No neurological clinical lesion was observed in rabbits 
receiving saline or Ropivacaine within the 7 days after the last Intrathecal injection, and 
histopathologic study revealed no sign of neurotoxicity in these groups. In contrast, Intrathecal 
Lidocaine induced clinical and histopathologic changes. They concluded that Ropivacaine induced 
dose-dependent spinal anesthesia, and did not induce any neurotoxicologic lesion in this experimental 
animal model. 
Motor sparing with Ropivacaine
4. McNamee et al, British Journal of Anaesthesia 2002; 89(5): 702-6 13
The aim of this study was to compare the safety and efficacy of Intrathecal plain Ropivacaine 17.5 mg 
and plain Bupivacaine 17.5 mg in patients undergoing primary total hip arthroplasty. 66 ASA I-III 
patients (43 male, 23 female; aged 33-78 years) were included in this randomized, double blind study. 
The group R received 0.5% Ropivacaine and group B received 0.5% Bupivacaine; both drugs were 
injected over 10 s. The results showed no difference in the median time of onset of sensory block 
between both groups. However, the Bupivacaine group (3.5 h) had a significantly longer median 
duration of sensory block than the Ropivacaine group (3.0 h). No significant differences were observed 
in the onset of motor block between both groups to achieve a Bromage score of 1, 2 and 3. However, 
the Ropivacaine group had a significantly shorter median duration of complete motor block than the 
Bupivacaine group. Furthermore, the degree of motor block after surgery was lower in the 
Ropivacaine patients compared with patients receiving Bupivacaine. The authors conclude that 
"Intrathecal administration of both 17.5 mg plain Ropivacaine or 17.5 mg plain Bupivacaine was well 
tolerated and an adequate block for total hip arthroplasty was achieved in all patients. A more rapid 
postoperative recovery of sensory and motor function was seen in the Ropivacaine group compared 
with the Bupivacaine group".
5. Lee YY, Ngan Kee WD, Muchhal K, Chan CK. 1: Acta Anaesthesiol Scand. 2005 Nov; 49(10): 
1477-82 15 
This was a prospective randomized double-blind study conducted in 34 ASA I-III patients scheduled 
for urological surgery were randomly assigned to receive Intrathecal injection of either plain 
Ropivacaine 10 mg with Fentanyl 15 μg (Ropivacaine group) or plain Bupivacaine 10 mg with 
Fentanyl 15 μg (Bupivacaine group) using a combined spinal-epidural technique. All patients achieved 
sensory block to the T10 dermatome or higher at 15 min after Intrathecal injection. One patient in the 
Ropivacaine group was excluded because of unexpectedly prolonged surgery. 
The primary outcome, the duration of motor block, was shorter in the Ropivacaine group (median, 126 
min; interquartile range, 93-162 min) compared with the Bupivacaine group (median, 189 min; 
interquartile range, 157-234 min; difference between medians, 71 min; 95% confidence interval, 
28-109 min; P = 0.003). The duration of complete motor block was also shorter in the Ropivacaine 
group compared with the Bupivacaine group. There was no difference in the onset time of motor block. 
The characteristics of sensory block and the haemodynamic changes were similar between the groups. 
They concluded that plain Ropivacaine 10 mg plus Fentanyl 15 μg provided similar sensory 
anaesthesia, but with a shorter duration of motor block, compared with plain Bupivacaine 10 mg 
plus Fentanyl 15 μg when used for spinal anaesthesia in urological surgery.
6.  Camorcia M, Capogna G, Lyons G, Columb MO, Anesth Analg. 2004 Jun; 98(6): 1779-82 16
This study established the median effective dose (ED (50)) for motor block of Intrathecal 1% and 0.1% 
Ropivacaine and determined the effects of the concentration of the solution injected on the motor block 
obtained. Study was done in 54 parturients undergoing elective Cesarean delivery under combined 
spinal-epidural technique. Parturients were randomized to receive Intrathecal Ropivacaine either 1% or 
0.1%. The initial dose was chosen to be 4 mg, with subsequent doses being determined by the response 
of the previous patient (testing interval, 1 mg). The occurrence of any motor block in either lower limb 
within 5 min from the Intrathecal injection of the study solution was considered effective. They 
concluded that The ED (50) of spinal Ropivacaine to produce motor block in pregnant patients was 
significantly influenced by the concentration of the local anesthetic, with dose requirements being 
increased by 50% for the smaller concentration. The minimum local anesthetic dose for motor block 
with 0.1% Ropivacaine is 50% larger than the 1% concentration with a relative efficacy ratio of 1.5. 
They suggested that more diluted local anesthetic solutions determine less motor block, and this 
may be considered in ambulant laboring parturients.
7. Wille M. Acta Anaesthesiol Belg. 2004; 55(3): 251 17
In their review, they concluded, “In order to further improve and understand safety issues as well as the 
clinical use of spinal anesthesia, new local anesthetics and analgesic additives are being investigated 
for different applications.
As practice of medicine focuses increasingly on outpatient care, spinal anesthetics should provide 
short-acting and adequate anesthesia without compromising early ambulation and discharge from the 
day surgery unit. A review of the current literature suggests that Ropivacaine could have potential in 
this area”.
Potency of Ropivacaine
8. Capogna G et al. Br J Anaesth 1999; 82; 371–3 22
Double blind sequential allocation to compare the minimum local analgesic concentrations (MLAC) of 
epidural Bupivacaine and Ropivacaine for women in the first stage of labor. The test bolus was 20 ml 
of local anaesthetic solution. The concentration was determined by the response of the previous woman 
to a higher or lower concentration of local anaesthetic, according to up-down sequential allocation. 
Efficacy was assessed using a 100-mm visual analogue pain score (VAPS). The test solution had to 
achieve a VAPS of 10 mm or less to be judged effective. For Bupivacaine, MLAC was 0.093 (95% CI 
0.076-0.110)% w/v, and for Ropivacaine, 0.156 (95% CI 0.136-0.176)%w/v (P < 0.0001, 95% CI 
difference 0.036-0.090). The analgesic potency of Ropivacaine was 0.60 (0.47-0.75) relative to 
Bupivacaine.
9. Terrance W. Breen, MD; David C. Campbell, MD; Jean E. Kronberg, MD; Robert T. Nunn, 
MD; Gordon H. Fick, PhD 1. Br J Anaesth 1999; 82:371-3 23
 The authors did a study to determine the relative potencies of Ropivacaine and Bupivacaine by 
allowing patients to titrate their analgesia using PCEA. Patients received 30% of their analgesia via the 
background infusion and controlled 70% (PCEA or by requesting top-ups). Therefore, this study shows 
that when patients are responsible for delivering their own analgesia they require almost identical 
amounts of Ropivacaine and Bupivacaine. MLAC studies have shown that at the ED50 dose, 
Ropivacaine is less potent than Bupivacaine. As the effective analgesia doses are the same, the dose-
response curves must be different. Further studies are needed to determine the ED90 or ED95 doses of 
Ropivacaine and Bupivacaine are clinically equipotent when providing labor epidural analgesia. 
“Therefore, outcome studies using the same concentrations of Ropivacaine and Bupivacaine are 
valid and will yield important information.”
10. Sia AT, Goy RW, Lim Y, Ocampo CE Anesthesiology. 2005 Mar; 102(3): 651-6 24
 In this double-blind study, 100 parturients in early labor were randomized to receive either Intrathecal 
Ropivacaine or LevoBupivacaine. For each drug, the patients were assigned to receive one of the five 
doses studied, namely 1, 1.5, 2, 2.5, or 3 mg. Effective analgesia was defined as a pain score (0-100 
visual analog scale) of less than 10 within 15 min of injection, lasting for 45 min or more after the 
induction of analgesia.  The duration of analgesia rendered by the two drugs at 2.5 and 3 mg was also 
compared. In their study LevoBupivacaine was found to be 1.31 (95% confidence interval, 1.04-2.01) 
times more potent than Ropivacaine. At doses of 2.5 mg or greater, there was no significant difference 
in duration of analgesia between levoBupivacaine (median, 63.5 min; range, 46-123 min) and 
Ropivacaine (median, 59.0 min; range, 47-93 min; P = 0.18). They detected no difference in the 
incidence of hypotension, nausea and vomiting, motor block, or abnormal fetal heart tracing between 
the two drugs. 
They concluded that MED of Intrathecal Ropivacaine for labor analgesia was significantly 
greater than levoBupivacaine experimentally, but this significance was reduced when the comparison 
was based on molar potency. There was no difference in the duration of analgesia or adverse 
effects between the two drugs at higher doses (2.5 mg or greater).
Intrathecal Ropivacaine with Fentanyl for Labor Analgesia
11. D. Hughes, D. Hill and J. P. H. Fee, British Journal of Anaesthesia, 2001, Vol. 87, No. 5 
733-737 25
The authors compared Ropivacaine 2.5 mg in the Intrathecal injection with a standard Bupivacaine CSE 
in a double-blind study. Forty women were randomized to receive either Bupivacaine 2.5 mg or 
Ropivacaine 2.5 mg intrathecally, both with Fentanyl 0.025 mg. There were no significant differences 
between the groups regarding the onset, duration or quality of analgesia or the level of sensory block 
attained. Forty per cent of the women (8/20) receiving Bupivacaine developed detectable motor block 
compared with only 5% (1/20) in the Ropivacaine group (P<0.05). Vibration sense was impaired in one 
woman in each group. Adverse effects did not differ between groups. They concluded that Intrathecal 
Ropivacaine 2.5 mg in combination with Fentanyl 0.025 mg as part of a CSE technique provides rapid 
and safe analgesia for labour as effective as that achieved with Bupivacaine 2.5 mg and with 
significantly less motor block. 
12. Craig M. Palmer, M.D.; Wallace M. Nogami, M.D.; Diane Alves, R.N. Anesthesiology 1999; 
91:84-89. Anesthesiology 1999; 90:944-950: Br J Anaesth 1999; 82:371 26
 Studied 49 ASA I and II nulliparous term parturients in active labor, patients were randomized to one 
of three groups to receive either Fentanyl 25 μg (I, n=16); Fentanyl 25 μg and Ropivacaine 2 mg (II, 
n=17); or Fentanyl 25 μg and Ropivacaine 4 mg (III, n=16) Intrathecally as part of a combined spinal 
epidural technique Duration of analgesia in both Ropivacaine groups (II & III) was longer than the 
plain Fentanyl group (I)(ANOVA, p<0.05), but groups II and III were not different from each other (I: 
74 +/- 5 minutes; II: 97 +/- 8 minutes; III: 107 +/- 7 minutes, mean +/- SEM). Onset of analgesia was 
similar among all three groups, with no differences noted (two-way ANOVA, p=N.S.). No patient in 
any group developed clinically detectable weakness (modified Bromage score < 6). Pruritus scores at 
20 minutes were not different among groups (range 30 - 33, scale 0 - 100, ANOVA p=N.S.). They 
concluded that addition of Ropivacaine, 2 or 4 mg, to Fentanyl 25 μg significantly prolonged the 
duration of analgesia, similar to the addition of Bupivacaine to Fentanyl1. Unlike Bupivacaine however, 
Ropivacaine did not speed the onset of analgesia or decrease the severity of pruritus. Based on relative 
potency studies of the two local anesthetics, the 2 and 4 mg doses of Ropivacaine were chosen for 
study as roughly equipotent to Bupivacaine 1.25 and 2.5 mg, respectively. Assuming these doses are 
equipotent, there appears to be little difference between the local anesthetics as adjuncts to Intrathecal 
Fentanyl for labor analgesia.
13.  Levin A, Datta S, Camann WR.  Anesth Analg. 1998 Sep;87(3):624-7 27 
The authors compared two doses of Intrathecal Ropivacaine combined with Sufentanil with a standard 
dose of Intrathecal Bupivacaine plus Sufentanil for labor analgesia using a combined spinal-epidural 
(CSE) technique. In a prospective, randomized, double-blind fashion, 48 patients requesting labor 
analgesia received either 2.5 mg of Intrathecal Bupivacaine plus Sufentanil 10 μg (B), 2 mg of 
Intrathecal Ropivacaine plus Sufentanil 10 μg (R2), or 4 mg of Intrathecal Ropivacaine plus Sufentanil 
10 μg (R4). Duration of analgesia and side effects, such as motor block, pruritus, hypotension, 
ephedrine requirements and fetal bradycardia, were recorded. 
                Duration of analgesia (mean +/- SD) was 79+/-30 min for R2, 98+/-19 min for R4, and 
92+/-38 min for B (P = not significant). No differences in motor block or side effects were detected 
among the groups. They concluded that Ropivacaine, when combined with Sufentanil, is effective for 
providing CSE labor analgesia and offers no advantage over Bupivacaine in the studied doses. In this 
study, they compared a standard dose of Intrathecal Bupivacaine with Sufentanil for combined spinal 
epidural analgesia with two doses of the new local anesthetic Ropivacaine. Both local anesthetics 
provided similar labor analgesia duration with equivalent side effect profiles in the doses studied.
14. M. K. Shah, A. T. H. Sia and J. L. Chong, Anaesthesia
Volume 55 Page 1008 - October 2000 29
Sixty patients in early labor were randomly allocated to one of three groups. The control group 
received Intrathecal Fentanyl 25 µg; the Ropivacaine group received Intrathecal Fentanyl 25 µg and 
Ropivacaine 2.5 mg while the Bupivacaine group received Intrathecal Fentanyl 25 µg and Bupivacaine 
2.5 mg. The incidence of pruritus was 100% in controls, compared with 85% in the Ropivacaine group 
(not significant) and 75% in the Bupivacaine group (p = 0.003). The severity of pruritus was 
significantly less in the Ropivacaine (p = 0.006) and Bupivacaine (p = 0.001) groups. Most patients 
developed pruritus by 30 min. Pruritus above the abdomen was not reduced in patients receiving local 
anesthetics. There were no significant differences in the mean pain visual analogue score, systolic 
blood pressure, maternal heart rate and upper level of reduced pin-prick sensation in the first 30 min. 
Intrathecal Ropivacaine and, more so, Intrathecal Bupivacaine reduce the incidence and severity of 
pruritus from Intrathecal Fentanyl for labor analgesia.
Balance function after CSE for Labor analgesia
15. Pickering AE, Parry MG, Ousta B, Fernando R. Anesthesiology. 1999 Aug; 91(2): 436-41 30 
The authors undertook a prospective controlled observational study using computerized dynamic 
posturography to examine balance function in pregnant women after combined spinal-epidural 
analgesia. 
The authors performed posturographic testing on 44 women in labor after institution of regional 
analgesia and compared them with a control group of 44 pregnant women. A separate group of six 
women were tested both before and after combined spinal-epidural analgesia. Neurologic examination 
after regional analgesia showed two parturients (4%) to have motor weakness (excluded from 
posturography). Four women (9%) had clinical dorsal column sensory loss; these women all completed 
posturography. The spinal-epidural analgesia group showed a small, statistically significant reduction 
in one of six posturographic sensory-organization tests; however, this difference was functionally 
minor. There were no other differences in posturography between the control and spinal-epidural 
groups. Similar results were found in the paired study, in which there was minimal change in balance 
function after spinal-epidural analgesia. 
This is the first study to objectively examine the effect of spinal-epidural analgesia on balance function. 
Using computerized dynamic posturography the authors were unable to find any functional 
impairment of balance function after spinal-epidural ambulatory analgesia in women in labor 
who had no clinical evidence of motor block.
Effect of Epidural test dose on motor blockade
16. Calimaran Al et al, Anaesth Analg 2003 Apr 96: 1167-72 33 
The authors conducted a study to test the effect of standard epidural test dose (3ml lignocaine 1.5% 
with epinephrine 1:200,000) on motor block in CSE labor analgesia. Homodynamic variables, 
proprioception, straight leg rising, and the modified Bromage score was analyzed in 110 parturients 
who completed the study protocol and were not different between groups. Vibratory sense the ability to 
perform a partial deep knee bend and to step up on stool and the subjective ability to walk were 
impaired in large number of parturients in the lignocaine epinephrine group at 30 min (p<0.05). They 
concluded that a standard lignocaine epinephrine epidural test dose injected immediately after the 
initiation of combined spinal epidural labor analgesia with Bupivacaine 2.5 mg and Fentanyl 25 μg 
may interfere with the ability to perform simple tests of motor function and ambulation.
Effect of addition of epinephrine to Intrathecal Fentanyl
17. Goodman SR et al, Reg Anes Pain Med 2002 Jul – Aug 27:374-9 34
The authors did a study to find the efficacy of epinephrine in prolonging Fentanyl induced labor 
analgesia. They used four groups divided to receive Fentanyl 35 μ g with either saline (F); Bupivacaine 
2.5 mg+ Saline (FB); Bupivacaine 2.5mg + Epinephine 100 μ g (FBE); or Epinephrine 100 μ g +saline 
(FE). The study showed hat Intrathecal Bupivacaine significantly prolonged Fentanyl analgesia with or 
without epinephrine (p = 0.018), but epinephrine did not significantly prolong the duration of 
Fentanyl alone or with Bupivacaine.
Needle through needle technique for CSE
18. Rawal N et al, Anesthesiolo Clinic North America 2000 Jun 18:267-9 35 
Concluded that CSE technique by “needle through needle technique” resulted in better epidural 
catheter sitting. He also concluded that the concern about epidural catheter entering through small dural 
hole is unfounded.
MATERIALS AND METHODS
This is a prospective, randomized, double blinded, control study. Prior approval was obtained 
from the ethical committee of GOVERNMENT STANLEY MEDICAL COLLEGE AND 
HOSPITAL and RSRM lying in hospital for the study. Fifty parturients who were admitted to the 
antenatal ward and who requested pain relief during labor were selected for the study. The procedure 
and complications of regional analgesia was explained to them in detail and written consent was 
obtained from them.
Inclusion criteria: 
1 Patients in established labor (cervical dilatation 3-5cms).
2 Patients belonging to ASA I.
3 Only primigravida patients with singleton pregnancy, in full term labor were included in the 
study.
Exclusion criteria:
1. PIH, DM, bleeding disorder or other systemic disorders.
2. Patients who have already received any Opioid drugs or systemic analgesics within prior 
24 hours.
3. Any contraindication for central neuraxial techniques.
4. Patients with known allergy to local anaesthetic or other drugs.
5. Patient refusal for regional technique.
The patients were randomly divided into two groups of twenty-five each. 
Group I (Bupivacaine): Received 2.5mg Bupivacaine with 0.025mg Fentanyl (total 
volume  1  ml)  Intrathecally,  followed  by  epidural  drugs  (0.1%  Bupivacaine  with  2µg/ml 
Fentanyl) as 5 ml top-ups. At the start of second stage of labor a top-up of 10 ml bolus was 
used. The top-ups were given only when the patient requested additional pain relief.
Group II (Ropivacaine):  Received 2.5mg Ropivacaine with 0.025mg Fentanyl (total 
volume  1  ml)  Intrathecally,  followed  by  epidural  drugs  (0.1% Bupivacaine  with  2µg/ml 
Fentanyl) as 5 ml top-ups. At the start of second stage of labor a top-up of 10 ml bolus was 
used. The top-ups were given only when the patient requested additional pain relief.
Since  the  study  period  ended  when  the  patient  requested  for  further  analgesia  by 
Epidural rote after initial Intrathecal injection, both the groups received same drugs via the 
Epidural route for the purpose of standardization. A standard Epidural test dose itself will result 
in  augmentation  of  motor  blockade.  Further,  the  addition  of  epinephrine  to  confirm 
intravascular placement is not reliable in active labor. Hence the test doses were done away 
with. Rather the bolus itself was given in two divided doses with 5 mins interval for motor 
block after the first dose.
The procedure was clearly explained to the patient. The visual analog scale was shown to them 
and interpretation of the scale explained in detail. The patients were shifted to the operation theatre for 
insertion of the epidural catheter in aseptic manner.
Anaesthesia machine was checked and all emergency airway equipments like Laryngoscopes, 
blades of different sizes, endotracheal tubes, LMAs, Oropharyngeal airways were kept ready.  An 
emergency drug tray containing all the emergency drugs was also kept ready.
IV access was secured with an 18G venflon. All patients included in the study were preloaded 
with 1000ml of Lactated Ringer’s Solution. Patient's vital parameters like heart rate, blood pressure, 
SPO2, respiratory rate and fetal heart rate were continuously monitored during the procedure. The base 
line values were recorded. The drugs to be administered Intrathecally were prepared and stored in a 
sterile container.
Equipment
The needles used for both groups were 16 G Tuhoy needle, 18 G epidural catheter and 26 G 
pencil point long spinal needle (CSE cure by Portex)
Procedure
With the patient in left lateral position, under strict aseptic precaution L2-L3 interspace was 
identified and skin infiltration was done with 1.5ml of 2% lignocaine. Using a 17G Tuohy needle and 
‘loss of resistance to air’ technique the epidural space was identified. 
Intrathecal injection was performed using long spinal needle (25G Whitaker) through epidural 
needle (needle through needle technique) over 10 sec. Immediately following this 19G epidural 
catheter was inserted and 3 cms kept inside the epidural space. The catheter was tapped firmly to the 
back. The patient was turned to supine position. Epidural top-ups were not given till patient complained 
of pain or discomfort. 
With the catheter in place patients were shifted to the labor ward after 20 minutes of 
observation in operation theatre, where they were closely monitored till delivery. A single operator was 
involved in all cases and position of epidural catheter was checked by aspiration for blood/CSF. Both 
the patient and observer were blinded to the contents of Intrathecal injection, the same two observers 
being involved in all cases. The study period commenced after the Intrathecal injection and ended 
at the request for further analgesia by epidural bolus.
The following parameters were observed 
1. HR, BP, SPO2, FHR, Respiratory rate at 0, 5, 15, 30, 60 mins and fifteen minutes 
thereafter.
2. Time of onset of analgesia – time of Intrathecal injection to the time of perception of 
first painless contraction.
3. Level of sensory blockade with loss of sensation to pin prick.
4. Duration of analgesia – defined as interval between Intrathecal injection and request for 
first epidural top up.
5. Visual analog pain scale (VAS)
6. Motor block by Modified Bromage scale
Grade Level of motor blockade Clinical assessment
0 Nil Free movement of legs and feet
1 Partial
Just able to flex the knees, 
free movement of feet
2 Almost complete
Unable to flex knees, free movement
Of feet possible
3 Complete Unable to move both legs and feet
7. Hourly cervical dilatation.
8. Mode of delivery, duration of labor.
9. Birth weight of baby and Apgar score at 1 and 5 mins.
10. Patient comfort, satisfaction (4- Excellent, 3- Good, 2- Fair, 1- Poor)
11. Side effects – Hypotension, nausea & vomiting, Pruritus, respiratory depression, urinary 
retention etc.
The patients were informed to ask for additional pain relief even when they felt mild 
discomfort/pain. The routine obstetric practice was allowed to continue. In our institution obstetricians 
give Inj.Oxytocin infusion for most of the patients to accelerate labor.  Artificial rupture was done if 
indicated. During the entire labor the mothers were positioned supine with left side tilt. If the patients 
were willing they were allowed to ambulate after assessing their motor power. The following tests were 
done sequentially to assess their motor power.
• Straight leg raising
• Sit at edge of cot unsupported
• Stand for a minute without support
• Perform a deep knee bend test
• Take three unassisted steps.
RESULTS
The study was conducted in Government RSRM Lying in hospital during 2005-20065. Fifty 
patients in active labor (Cervix dilation 3-4 cms) who requested analgesia were chosen and randomly 
assigned to either of the two groups.
The patients were randomized into two groups Group 1 and Group 2 of 25 each all the patients 
had delivery via naturalis .The trial numbers were 25 in each group.
Group 1: Intrathecal Bupivacaine with Fentanyl.
Group 2: Intrathecal Ropivacaine with Fentanyl.
The following are the observations made during the study.
Physical Characteristics
Physical characteristics like age, height and weight were comparable in both the groups.
Age distribution 
The age distributions in both groups are as shown in the table below. The distribution is similar 
in both groups and there is no statistical difference between the two groups.
TABLE I Age distribution
Parameters
Group I 
(Bupivacaine)
Group II 
(Ropivacaine)
No. Of cases studied 25 25
Mean 21.88 21.66
Standard deviation 2.108 1.952
T- test value = 0.35, P – value = 0.75 - Not significant, Student T – test
Weight Distribution
The distributions of weight in both the groups are shown in Table II. The values are similar in 
both groups and are statistically comparable. The Student T test done on the values revealed no 
statistical significance.
Table II Weight distribution
Parameters
Group I 
(Bupivacaine)
Group II 
(Ropivacaine)
No. Of cases studied 25 25
Mean 64.32 64.84
Standard deviation 7.353 7.454
T- test value = 0.25, P – value = 0.81 - Not significant,  Student T – test
Height Distribution
The distribution of height in both the groups is shown in Table III. The values are similar in 
both groups and are statistically comparable. The Student T test done on the values revealed no 
statistical significance.
Table III Height distribution
Parameters Group I (Bupivacaine)
Group II 
(Ropivacaine)
No. Of cases studied 25 25
Mean 158.24 159.32
Standard deviation 7.259 7.111
T- test value = 0.64, P – value = 0.94, Student T – test
Mode of Delivery 
One patient in the Bupivacaine group delivered by outlet forceps delivery. All others were 
delivered by Labor Natural with episiotomy. The indication for forceps delivery was maternal 
exhaustion. The baby was found to have cord around the neck during forceps delivery.
Table IV Mode of Delivery
Mode of Delivery
Group I 
(Bupivacaine)
Group II 
(Ropivacaine)
Labor Natural 24 25
Outlet Forceps 1 0
              
 Chi-square – 1.02, P-value 0.31
Duration of Labor
The total duration of labor in both groups is comparable. The duration of individual stages of 
labor are comparable in both groups. Students T- test was done on duration on total and each stage. The 
P-values are all > 0.05 implying that the differences were not statistically significant.
Table V Duration of Individual stages of labor
Stage of 
Labor
Group I 
(Bupivacine)
Group II 
(Ropivacaine)
Mean
(Mins) SD
Mean
(Mins) SD
T – test P- value
First Stage 146.40 28.994 142.60 34.191 0.42 0.64
Second 
Stage 53.20 12.819 51.00 10.607 0.66 0.51
Third 
Stage 15.20 5.299 17.40 4.813 1.53 0.13
                         
Table VI Total duration of labour
Parameters
Group I 
(Bupivacaine)
Group II 
(Ropivacaine)
Mean (hours) 3.55 3.48
Standard 
deviation
0.68 0.66
T- test value = 0.69, P – value = 0.71, Student T – test
Duration of Analgesia with First Dose
The duration of analgesia after giving the first  dose was compared for both the drugs .The 
duration was similar in both groups.
Table VII Duration of analgesia with first dose
Parameters
Group I 
(Bupivacaine)
Group II 
(Ropivacaine)
Mean
(Mins) SD
Mean
(Mins) SD
T – test P- value
Duration  of 
Analgesia 89.24 6.27 97.20 7.14 0.37 0.72
The student t–test done on these variables show no statistical difference between the two 
groups. 
Number of Top-ups given
There was no difference in the requirement of epidural top up in both the groups.
Table VIII Number of top-ups
Parameters Group I (Bupi) Group II (Ropi)
Mean 2.04 1.92
Standard Deviation 0.455 0.572
             
 Chi- square 0.82, P-value 0.42.
A Chi-square test done on these values showed no significant statistical difference between both 
the groups.
Total dose of Epidural drugs used
Table IX Total dose of Epidural drugs used
Drug
Group I 
(Bupivacine)
Group II 
(Ropivacaine)
Mean SD Mean SD
T – test P- value
Epidural Fentanyl 30.40µg 4.546 29.20 5.715 0.82 0.42
Epidural Bupivacaine 15.20mg 2.273 14.60 2.858 0.82 0.42
The total dose of Epidural Fentanyl and Epidural Bupivacaine used were similar in both groups 
and there was no statistical difference between the groups. 
Motor Blockade
This was assessed using the Modified Bromage Scale. 
92% (n = 23) of the patients in the Ropivacaine group had no motor blockade (Bromage Scale 
0) compared to 48% (n = 12) in Bupivacaine group. These patients felt very comfortable during 
ambulation. 
Only 8% (n=2) in Ropivacine Group when compared to 52% (n=12+1) in Bupivacaine Group 
had mild to moderate Motor Blockade (Bromage Scale 1 & 2), which made ambulation uncomfortable.
Table X Motor block
Bromage Scale
(MAX BLOCK)
Group I (Bupivacine) Group II (Ropivacaine)
N % N %
0 12 48 23 92
1 12 48 2 8
2 1 4 0 0
Chi-square 11.6,  P – value 0.01.
A Chi –square test showed significant statistical difference with regard to motor blockade 
between the two groups.
This clearly shows that Intrathecal Ropivacaine causes significantly less Motor Blockade when 
compared with Intrathecal Bupivacaine.
Sensory level
Patients in both groups had a mean sensory level of T8. The maximum was only T6 and 
minimum level was T10.
Table XI Sensory level
Sensory 
Level
Group I (Bupivacine) Group II (Ropivacaine)
N % N %
T 6 2 8 1 4
T 7 3 12 5 20
T 8 13 52 11 44
T 9 2 8 4 16
T 10 5 20 4 16
Chi square  - 0.00, P value 1.00
A Chi square analysis showed no statistical difference between the two groups in terms of 
sensory level of blockade.
VAS SCALE
The pain perceived by the patients was assessed by showing them a VAS scale which contained 
pictures of faces depicting pain on one end and smiling face on the other end. The other side had a 
scale marked from 0 to 100. The scale had a slider, which the patients move to point below the image, 
which they felt expressed their perceived pain.
The VAS score was assessed at 0, 5, 15, 30,45,60,90,120 and 180 minutes. Since the study 
period ended when the patient requested for first epidural top up, the Vas score till that time was taken 
for statistical analysis. The initial VAS score ranged between 80 and 100 for all the patients. Both 
groups had a rapid onset of pain relief and their VAS score fell to < 5 within    5 min in both groups. 
Table XII VAS SCORES
VAS Score 
(Time mins)
Bupivacaine Group Ropivacaine Group
Mean S.D t- test Mean S.D t- test
VAS 0 90.2000 6.37050 .195 92.4000 5.42371 .195
VAS 5 1.2000 2.98608 .271 .4000 2.00000 .272
VAS 15 2.6000 4.35890 .875 2.8000 4.58258 .875
VAS 30 2.0000 5.81881 .64 5.8000 6.72062 .65
VAS 60 4.4000 5.06623 .625 5.2000 6.37050 .625
VAS 90 4.2857 6.46206 .754 5.0000 6.72593 .753
No significant statistical difference between the two groups was noted.
Haemodynamic variables
All haemodynamics variables were recorded at 0mins(base line), 5mins, 15 mins, 30 mins, 45 
mins, 60 mins and thereafter every 15 minutes. The variables till the time when the patient received 
first epidural top up was taken for statistical analysis.
PULSE RATE
There was not much variation in the pulse rate recordings between the two groups. 
                                                Table XIII Pulse rate
MHR 
(at 
min)
 
 
Group
Bupivacaine Ropivacaine
Mean SD Mean SD
0 91.92 5.57 88.88 6.58
2 90.92 5.77 89.92 6.74
5 92.20 4.86 90.20 7.20
15 91.92 5.71 90.24 6.60
30 89.92 5.42 90.32 8.03
45 89.76 5.36 90.16 6.91
60 89.40 5.55 89.76 6.63
90 76.72 4.86 78.96 5.86
   
Table XIV  Repeated Measures of ANOVA
MHR F Sig
Within Group 74.39 .001
Between Group .16 0.69
The two-way ANOVA test done on the pulse rate recordings showed no statistical difference 
between the two groups. There was significant variation within the groups with time.
SYSTOLIC BLOOD PRESSURE
No statistically significant difference was noted between the groups with regards to the systolic 
blood pressure. 2 patients had hypotension (defined as systolic blood pressure less than 90 mm Hg) in 
Bupivacaine group and were treated with a single dose of 6mg Ephedrine IV. Both patients responded 
well to Ephedrine and did not require further boluses
Table XV  Systolic blood pressure
SBP (at 
min)
 
 
Group
Bupivacaine Ropivacaine
Mean SD Mean SD
0 114.24 8.33 117.44 8.05
2 115.60 7.51 117.44 9.19
5 118.08 9.46 116.68 10.92
15 120.16 9.61 116.80 9.35
30 121.76 8.63 115.68 7.52
45 120.72 7.93 114.56 7.49
60 122.08 7.54 113.44 7.15
90 113.92 7.18 109.36 8.30
                                      Table XVI  Repeated Measures of ANOVA
SBP F Sig
Within Group 5.57 .001
Between Group 3.87 .07
The two-way ANOVA test done on the recordings showed no statistical difference between the 
two groups. There was significant variation within the groups with time.
DIASTOLIC BLOOD PRESSURE
The two groups had no significant difference in the diastolic blood pressure as was seen in the 
systolic blood pressure. The two-way ANOVA test showed no statistical difference between the two 
groups. There was significant variation within the groups with time.
Table XVII Diastolic blood pressure
DBP 
(at 
min)
Group
Bupivacaine Ropivacaine
Mean SD Mean SD
0 75.68 6.75 74.80 6.48
2 76.40 5.94 73.20 7.55
5 74.32 6.80 74.08 7.86
15 74.40 5.74 74.64 5.91
30 71.84 15.04 73.44 5.64
45 75.28 6.43 73.52 5.04
60 74.16 6.30 75.12 3.96
90 77.84 7.26 78.40 4.76
Table XVIII Repeated Measures of ANOVA
DBP F Sig
Within Group 2.85 0.007
Between Group 0.10 0.75
FETAL HEART RATE
There was not much variation between the two groups and the ANOVA test did not show any 
statistical significance between the two groups though there was variation within both groups with 
time. 
Table XIX Fetal heart rate
FHR 
(at 
min)
Group
Bupivacaine Ropivacaine
Mean SD Mean SD
0 147.96 5.14 147.80 7.26
2 147.00 4.75 148.64 6.63
5 147.64 5.54 148.72 6.58
15 148.60 5.22 150.24 6.80
30 147.28 6.46 149.80 5.94
45 148.40 5.51 150.28 6.99
60 148.48 3.89 149.16 7.19
90 142.40 5.65 143.40 6.70
Table XX Repeated Measures of ANOVA
FHR F Sig
Within Group 9.76 .01
Between Group 1.18 0.28
PATIENT COMFORT LEVEL
This was assessed by asking the patient how they felt at the end of the delivery. Majority of the 
patients (80%) in Ropivacaine group had excellent pain relief whereas in the Bupivacaine group 72% 
had good pain relief and 28% had excellent relief. This was assessed on a scale as follows
Table XXI Patient comfort level
Comfort level
Group I 
(Bupivacine)
Group II 
(Ropivacaine)
N % N %
1 – Poor 0 0 0 0
2 – Fair 0 0 0 0
3 – Good 7 28 5 20
4 – Excellent 18 72 20 80
Chi – square = o.44, P value   = 0.51.
APGAR SCORE
APGAR score estimated at one and five minutes are tabulated below
Table XXII One minute APGAR
APGAR 1 Group I (Bupivacine) Group II (Ropivacaine)N % N %
5 10 40 7 28
6 4 16 5 20
7 5 20 5 20
8 6 24 8 32
9 0 0 0 0
10 0 0 0 0
      
  χ2 = 0.93, p=0.82, P value by Chi square test did not show statistical difference.
Table XXIII Five minute APGAR
APGAR 5 Group I (Bupivacine) Group II (Ropivacaine)N % N %
5 0 0 0 0
6 0 0 0 0
7 3 12 6 24
8 16 64 12 48
9 6 24 7 28
10 0 0 0 0
       
 χ2 =1.65, p=0.44  P value by Chi Square did not show any statistical significance
Table XXIV Complications
Complication Group I (Bupivacaine)
Group II 
(Ropivacaine)
Hypotension 2 0
Pruritis 2 3
Respiratory depression 0 0
Vomiting 1 2
Urinary retention 2 3
Intravenous Catheter Placement 0 0
Post dural puncture headache 0 0
Neurological complications 0 0
Hypotension (SBP < 90 mmHg or < 30% of baseline) was present in two cases in Bupivacaine 
group.  Both cases responded to 6 mg of Ephedrine IV. Pruritus was also present in both groups 2 in the 
Bupivacaine and 3 in the Ropivacaine group. It was only mild and reassurance was all that was needed. 
One patient each in Bupivacaine group and 2 patients in Ropivacaine group had vomiting (one 
episode). 5 patients had urinary retention two in Bupivacaine and 3 in Ropivacaine group. Their 
bladder was emptied by simple catheterization. Both the groups had no incidence of intravascular 
catheter placement, PDPH or any neurological complications.
DISCUSSION
     Of all the methods of pain relief that can be used in Labor, neuraxial blockade (Epidural, 
Spinal, Combined spinal epidural, Continuous spinal) provides the most effective and least 
depressant analgesia. Out of these, studies by Collins et al1, Landau et al 2  , Norris et al3 and 
Dressner et al4 has shown that CSE combines the advantages of a Spinal analgesia (rapid onset, 
reliable analgesia and less motor blockade) with the additional flexibility of renewal with 
epidural catheter.
     Collis and colleagues 1 reviewed a series of 300 women receiving CSE analgesia and found 
51.3% of the women were able to bear weight and were fully ambulant. Although others were 
sufficiently mobile to sit in a chair or to be mobile in their bed, almost 13% experienced severe 
motor weakness that rendered them immobile in the first stage of labor. Thus this finding 
implies that though CSE decreases the degree of motor blockade there is still scope for 
improvement. So in our study we tried to further decrease the incidence of motor blockade in 
CSE.  
     Ropivacaine is a local anesthetic with lower cardio toxic potential than racemic 
Bupivacaine38,39,40,41,42. Intrathecal Ropivacaine does not produce any signs of neurotoxicity following 
administration to rats and Rabbits 8,9,5. In dogs intrathecal Ropivacine has been shown to produce 
effective local anaesthesia with an equipotent sensory block but shorter duration of motor block than 
intrathecal bupivacaine10. In humans, Ropivacine has been shown to be effective in providing 
intrathecal anaesthesia for patients undergoing total hip replacement13, Knee arthroscopy6 , transurethral 
resection of the prostate21, and lower abdominal or limb surgeries7,14. Ropivacaine has been reported 
to cause significantly less motor blockade than Bupivacaine when administered by the 
Intrathecal route13,14,15,16,17,18,19,20,21. Hence we decided to investigate its potential for motor 
sparing when used Intrathecally for labour analgesia  
                     Capogna et al22 did a double blind sequential allocation to compare the minimum local 
analgesic concentrations (MLAC) of epidural Bupivacaine and Ropivacaine for women in the first 
stage of labor. They inferred that the analgesic potency of Ropivacaine was 0.60 (0.47-0.75) relative to 
Bupivacaine.  In another interesting study by Terrance et al23, the authors tried to determine the relative 
potencies of Ropivacaine and Bupivacaine by allowing patients to titrate their analgesia using PCEA. 
Patients received 30% of their analgesia via the background infusion and controlled 70% (PCEA or by 
requesting top-ups). The study showed that when patients are responsible for delivering their own 
analgesia they require almost identical amounts of Ropivacaine and Bupivacaine. The authors 
concluded, “Outcome studies using the same concentrations of Ropivacaine and Bupivacaine are 
valid and will yield important information.” In our study we compared equal doses of both local 
anesthetics.
     Little has been published on the use of Ropivacaine for Intrathecal labor 
analgesia25,26,27,28,29,30,31,32. D. Huges and colleagues25 compared similar doses of Intrathecal 
Ropivacaine (2.5 mg) with Intrathecal Bupivacaine (2.5 mg) both with 25 micro g Fentanyl for 
Labor analgesia and concluded that Intrathecal Ropivacaine 2.5 mg in combination with Fentanyl 
0.025 mg as part of a CSE technique provides rapid and safe analgesia for labour as effective as that 
achieved with Bupivacaine 2.5 mg and with significantly less motor block. 
  W. Levin and colleagues27 compared two doses of Ropivacaine (2 and 4 mg) with Bupivacaine 
2.5 mg in a CSE technique and found no difference in duration or quality of analgesia. They 
also reported no motor block in any of the women, including those receiving Intrathecal 
Bupivacaine. The Opioid used in conjunction with the local anaesthetic was Sufentanil.
      In our study we compared equal doses of local anaesthetic (2.5 mg in both groups) and 
combined this with Fentanyl 0.025 mg in a total of 50 patients (25 in each group). We chose 
motor power retention as a major end-point.    
     There as no difference in the demographic variables between both the groups. 
    Our most significant finding was the difference in detectable motor block between the two 
groups. Only two patients (8%) in the Ropivacaine group developed leg weakness (all Bromage 
scale 1) compared with thirteen patients in the Bupivacaine group (52%) (including Bromage 
scale 1 and 2). All other patients had a Bromage scale of 0 and were ambulant without any 
difficulty (92% in Ropivacaine group and 48% in Bupivacaine group). This difference was 
statistically significant (P=0.01). These results are similar to that inferred by Huges et al25 who 
reported 4% incidence of detectable motor blockade in Ropivacine group versus 40% in 
Bupivcaine group.  As mobility has been a major consideration in the development and 
popularity of CSE analgesia in labor, this finding may have important clinical implications. 
Further dose-finding studies would be required to know that this difference is due to an 
intrinsic property of Ropivacaine or to a difference in potency between Ropivacaine and 
Bupivacaine. 
Both groups were comparable with regard to the onset, duration and quality of analgesia and 
level of sensory blockade. This was similar to those observed in other studies25,26,27. While both drugs 
provided adequate and good pain relief, the lesser degree of motor blockade and consequent ease in 
ambulation in the Ropivacaine group had good psychological impact on the patients. 
In our study both groups needed similar number of epidural topups. There was not much 
difference in the overall comfort level between the two groups which was assessed by asking how the 
patients felt at the end of the delivery.  
The total duration of labor and the duration of individual stages of labor were comparable in 
both groups and this was similar to other studies25,26,27,29,31,32. Students T- test was done on the Total 
duration and on the duration of each stages. The P-values are all > 0.05 implying that the differences 
are not statistically significant.
One patient in the Bupivacaine group was delivered by outlet forceps delivery. All others were 
delivered by labor natural with episiotomy. The indication for forceps delivery was maternal 
exhaustion. The baby was found to have cord around neck during forceps delivery. The Apgar score 
observed at 1 mt and 5 th mt showed no significant neonatal depression.
The blood pressures (both systolic and diastolic) and pulse rate recorded during the analgesia in 
both the groups were not stastically different with minor episodes of hypotension, which responded to 
IV ephedrine. Pruritus was also present in both groups, two in the Bupivacaine and three in the 
Ropivacaine group. It was only mild and reassurance was all that was needed. One patient in 
Bupivacaine and two patients in Ropivacaine group had vomiting (one episode). 5 patients had urinary 
retention (2 in Bupivacaine group and 3 in Ropivacaine group). Their bladder was emptied by simple 
catheterization. No incidences of PDPH or neurological complications were noted in either group. 
Although previous studies have linked intrathecal Ropivacine with an increased incidence of post-dural 
puncture headache7 and low back pain28, no patient in the present study reported symptoms in keeping 
with these two complications. This is in agreement with the findings of others5,6,13. 
SUMMARY
In our study both the drugs (Intrathecal Ropivacaine and Bupivacaine with Fentanyl) provided good 
pain relief while the incidence of motor blockade was significantly less in Ropivacaine group when 
compared with Bupivacaine group.
The two drugs did not influence the outcome of labor such as the duration of labor or the 
type  of  delivery.  There  was  no  adverse  fetal  outcome  in  both  the  groups.  Sensory 
blockade levels were similar in both the groups.
Both the drugs had lesser impact on the haemodynamics. Complications were only few, 
were minor and easily manageable.
CONCLUSION
In our study we conclude that Intrathecal Ropivacaine 2.5mg in combination with Fentanyl 25 
micrograms as a part of CSE technique provides rapid and safe analgesia for labor as effective as that 
achieved by Bupivacaine 2.5mg with significantly less motor blockade. So it is an ideal drug to use for 
labour analgesia.
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Proforma - Ropivacaine/Bupivacaine in CSE for labor analgesia
Identification:
       Name: Age: I.P.No:   Unit:
Preop Assessment:
ASA:      Vitals: PR -      BP-       FHR-      VAS-     Cervix:      Presenting part:
     
Events:
Start of procedure (skin infiltration): Pain free contraction:
Epidural catheter placement: VAS<1:
Intrathecal drug administration:  I stage:
End of procedure (Pt placed supine):              II stage:
Onset of sensory loss:              Time of delivery:
Variable Basal   0 
min
 2 
min
  5 
min
 10 
min
  15 
min
 30 
min
  45 
min
  60 
min
120 
min
180 
min
240 
min
PR
BP
VAS
Sensory 
level
Bromage 
scale
FHR
Cervix
Epidural Topups
Time Total
Volum
e
Obstetric Intervention:
Oxytocin acceleration - Membrane rupture- other drugs:
Delivery   - LN   / LN with epi   / Instrumental   / Caesarian
Total duration of labor (I+II stage):  
Baby Apgar: 1 min-     5min-        
Patient Comfort – Excellent   / good   / fair   / poor   
Side effects: - Hypotension   / Bradycardia   / Nausea   / Vomiting   / Shivering   / 
Pruritus   / Resp dep   / Urinary retention   / others 
